(Q38733778)

5 September 2017

Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation (English)

1 reference

lysergic acid diethylamide

5 September 2017

1 reference

6

Erich Seifritz

1 reference

5 September 2017

Rainer Kraehenmann

1

1 reference

5 September 2017

Dan Pokorny

2

1 reference

5 September 2017

Leonie Vollenweider

3

1 reference

5 September 2017

Katrin H Preller

4

1 reference

5 September 2017

Thomas Pokorny

5

1 reference

5 September 2017

Franz X Vollenweider

7

1 reference

5 September 2017

7 April 2017

1 reference

5 September 2017

1 reference

5 September 2017

234

1 reference

5 September 2017

13

1 reference

5 September 2017

2031-2046

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-017-4610-0

5 September 2017

0 references

cites work

Global field synchronization reveals rapid eye movement sleep as most synchronized brain state in the human EEG

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Seeing with the eyes shut: neural basis of enhanced imagery following Ayahuasca ingestion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Serotonin 2A receptors and visual hallucinations in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Regional cerebral blood flow throughout the sleep-wake cycle. An H2(15)O PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

What geometric visual hallucinations tell us about the visual cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Was it a vision or a waking dream?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Neural correlates of the LSD experience revealed by multimodal neuroimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

The influence of ipsapirone, a 5-HT1A agonist, on sleep patterns of healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

A mathematical theory of visual hallucination patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Serotonin 2A receptor agonist binding in the human brain with [¹¹C]Cimbi-36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

On the arousal state-dependent recall of 'subconscious' experience: stateboundness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Dreams, Hallucinogenic Drug States, and Schizophrenia: A Psychological and Biological Comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Thinking and hallucinating: reciprocal changes in sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Inhibition of REM sleep by ipsapirone, a 5HT1A agonist, in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

An exploratory study of syncretic experience: eidetics, synaesthesia and absorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

The dreaming sleep stage: a new neurobiological model of schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Recent advances in the neuropsychopharmacology of serotonergic hallucinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Mental phenomena evoked by electrical stimulation of the human hippocampal formation and amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

REM sleep and dreaming: towards a theory of protoconsciousness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Human hallucinogen research: guidelines for safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Brain basis of self: self-organization and lessons from dreaming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Evidence for a functional interaction between 5-HT1A and 5-HT2 receptors in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Bizarreness in dream reports and waking fantasies of psychotic schizophrenic and manic patients: empirical evidences and theoretical consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Coherent 40-Hz oscillation characterizes dream state in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Functional neuroanatomy of human rapid-eye-movement sleep and dreaming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Cortical reactivity and effective connectivity during REM sleep in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Serotonin receptors: their key role in drugs to treat schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Broadband cortical desynchronization underlies the human psychedelic state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Dreaming and the brain: from phenomenology to neurophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

SSRI treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

The pharmacology of lysergic acid diethylamide: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Homological scaffolds of brain functional networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

A psychoanalytic view of sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Anomalies of Imagination and Disordered Self in Schizophrenia Spectrum Disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Further studies in the therapeutic value of lysergic acid diethylamide in mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

The therapeutic value of lysergic acid diethylamide in mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

The dream as a model for psychosis: an experimental approach using bizarreness as a cognitive marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Is it time to revisit the role of psychedelic drugs in enhancing human creativity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Genuine and drug-induced synesthesia: a comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Sleep on it, but only if it is difficult: effects of sleep on problem solving.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

A new psychotropic agent. Psychological and physiological effects of 2,5-dimethoxy-4-ethyl amphetamine (DOET) in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

DOET (2,5-dimethoxy-4-ethylamphetamine), a new psychotropic drug. Effects of varying doses in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Increased activation of indirect semantic associations under psilocybin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Human psychopharmacology of N,N-dimethyltryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Meta-Awareness During Day and Night

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Enhanced repertoire of brain dynamical states during the psychedelic experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

A placebo-controlled investigation of synaesthesia-like experiences under LSD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

21 January 2018

Drug-induced nightmares.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

A systems model of altered consciousness: integrating natural and drug-induced psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Induction of self awareness in dreams through frontal low current stimulation of gamma activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

21 January 2018

Sleep inspires insight

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4610-0

Contribution to serotonin theory of dreaming (LSD infusion)

21 January 2018

1 reference

12 December 2020

Cannabis use among a sample of 16 to 18 year-old students in Switzerland.

1 reference

12 December 2020

Self-Disturbance and the Bizarre: On Incomprehensibility in Schizophrenic Delusions

1 reference

12 December 2020

LSD and the sleep-dream cycle.

1 reference

12 December 2020

[Creativity and modification of consciousness]

1 reference

12 December 2020

The effect of LSD on the associative processes.

1 reference

12 December 2020

Intoxicant drugs (mescaline and lysergic acid diethylamide) in psychotherapy

1 reference

12 December 2020

The Single-Mindedness and Isolation of Dreams

1 reference

12 December 2020

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

12 December 2020

The multiple selection vocabulary test (MSVT-B)--an accelerated intelligence test

1 reference

12 December 2020

The effects of psilocybin on primary process content in language

1 reference

12 December 2020

Seeing scenes: topographic visual hallucinations evoked by direct electrical stimulation of the parahippocampal place area

1 reference

12 December 2020

Erratum: Complex brain networks: graph theoretical analysis of structural and functional systems

1 reference

12 December 2020

[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

1 reference

12 December 2020

(1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists

1 reference

12 December 2020

Guided affective imagery (GAI). A method of intensive psychotherapy.

1 reference

12 December 2020

Dreaming and REM sleep are controlled by different brain mechanisms

1 reference

12 December 2020

Pharmacokinetics of ketanserin in patients with essential hypertension

1 reference

12 December 2020

L.S.D. 25 as an aid in psychotherapy; preliminary report of a new drug.

1 reference

12 December 2020

The therapeutic role of 5-HT1A and 5-HT2A receptors in depression

1 reference

12 December 2020

Psychological aspects of the LSD treatment of the neuroses

1 reference

12 December 2020

Alterations in the nocturnal sleep cycle resulting from LSD

1 reference

12 December 2020

Variations in ego feeling induced by D-lysergic acid diethylamide (LSD-25)

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S00213-017-4610-0

Identifiers

DOI

1 reference

Dimensions Publication ID

5 September 2017

0 references

1 reference